A Novel Microfluidic Platform for Organoid Culture and Drug Screening

A Novel Microfluidic Platform for Organoid Culture and Drug Screening
A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening
A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening
A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening
A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening
A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening
A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening
A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening
A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.
